本页面由Tiger Trade Technology Pte. Ltd.提供服务

X4制药

2.60
-0.2200-7.80%
盘后:2.620.0200+0.77%19:30 EDT
成交量:43.96万
成交额:117.16万
市值:2.58亿
市盈率:-2.93
高:2.83
开:2.81
低:2.59
收:2.82
52周最高:4.83
52周最低:2.59
股本:9,914.67万
流通股本:6,235.43万
量比:0.77
换手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):-0.8867
每股收益(LYR):-1.8726
净资产收益率:-113.08%
总资产收益率:-28.15%
市净率:1.66
市盈率(LYR):-1.39

数据加载中...

2020/03/20

重要事件披露

Current report, item 5.02
2020/03/17

重要事件披露

Current report, items 1.01 and 2.03
2020/03/13

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/12

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, item 2.02
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, item 5.02
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/10

重要事件披露

Current report, items 2.02, 7.01, 8.01, and 9.01
2019/12/17

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/09

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/27

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/26

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/14

重要事件披露

Current report, items 1.01 and 2.03
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/11/07

季度报告

Quarterly report [Sections 13 or 15(d)]